A traditional Chinese herbal medicine compound preparation versus interventional therapy after resection of small hepatocellular carcinoma: 22-year follow up

$8.00
VAT Exempt
In stock
SKU
JTCM-545

To read the full abstract subscribe to the JCM online archive

The five-year recurrence rate of hepatocellular carcinoma (HC) after surgical resection is over 60 per cent. This retrospective study assessed the effects of compound Ruanjianhugan (RJH) tablets in 393 ...
More Information
Author Sun Zhen et al
JCM Issue JCM101-P80
Write Your Own Review
You're reviewing:A traditional Chinese herbal medicine compound preparation versus interventional therapy after resection of small hepatocellular carcinoma: 22-year follow up

* Orders shipped outside of Europe are eligible for VAT relief and will not be charged VAT.